SCHEMBL6608103

SCHEMBL6608103

Cc1cc2cc(N)ccc2n1Cc1ccccc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ MAPT P10636 4/20 0.44
▸ THRB P10828 1/20 0.44
▸ TP53 P04637 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ ECE1 P42892 5/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10413206 0.84 L3MBTL1 (0.54) ALDH1A1KMT2APOLBL3MBTL1MAPT
SCHEMBL6019265 0.79 NOD2 (0.52) ALDH1A1KMT2APOLBL3MBTL1MAPT
SCHEMBL6611835 0.78 CYP1A2 (0.50) ALDH1A1KMT2APOLBL3MBTL1MAPT
SCHEMBL6173849 0.77 KMT2A (0.43) ALDH1A1KMT2APOLBL3MBTL1TP53
SCHEMBL8334902 0.74 ECE1 (0.61) ECE1
SCHEMBL8334899 0.74 ECE1 (0.68) ECE1
SCHEMBL8338253 0.73 ECE1 (0.64) ECE1
SCHEMBL9958735 0.72 KDM4E (0.50) ALDH1A1KMT2APOLBMAPTTP53
SCHEMBL3321752 0.72 ALDH1A1 (0.50) ALDH1A1KMT2AL3MBTL1MAPTTP53
SCHEMBL23902668 0.71 PPARG (0.45) ALDH1A1MAPTTP53GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432415-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2004-06-30 — — EP disclosed
WO-2003028719-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2003-04-10 — — WO disclosed
Send feedback